Dr Reddy's Laboratories has announced the launch of its injectable semaglutide under the brand name Obeda, marking an important step in expanding access to GLP-1 receptor agonist-based therapy for the ...
Dr. Reddy’s Laboratories has launched ‘Obeda’, an injectable semaglutide therapy for diabetes and weight management in India.
A drug that cost over Rs 10,000 a month is now available for as little as Rs 220 a shot. Multiple companies have entered the ...
Financial data pours into accounting systems from all sorts of sources—banks, payment processors, spreadsheets, third-party apps—you name it. Each one has its o ...
MiniMax M2.7 fully tested as an agentic AI model, showing 30% autonomous self-improvement after 100+ self-training rounds.
Open AI models have become a cornerstone of modern innovation. From startups building new products to enterprises optimizing operations, organizations ...
Model selection, infrastructure sizing, vertical fine-tuning and MCP server integration. All explained without the fluff. Why Run AI on Your Own Infrastructure? Let’s be honest: over the past two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results